GAD⁶⁵ and Insulin B Chain Peptide (9-23) are not Primary Autoantigens in the Type 1 Diabetes Syndrome of the BB Rat

References

• Leiter E. H., Gill R. G. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. J. Endocrinol. Invest 1994; 17: 595–599
   PubMedGoogle Scholar
• Charlton B., Taylor C. E.-, Tisch R., Fathtman C. G. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J. Autoimmunity 1994; 7: 549–560
   PubMedGoogle Scholar
• Bach J. F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev 1994; 15: 516–542
   PubMed Web of Science ®Google Scholar
• Sernmark R. Immune surveillance: Paraneoplastic or environmental triggers of autoimmunity. Crit. Rev. Immunol 1997; 17: 437–447
   PubMedGoogle Scholar
• Ramiya V. K., Lan M. S., Wasserfall C. H., Notkins A. L., Maclaren N. K. Immunization therapies in the prevention of diabetes. J. Autoimmunity 1997; 10: 287–292
   PubMed Web of Science ®Google Scholar
• Xie H., Zhang B. W., Matsumoto Y., Li Q., Notkins A. L., Lan M. S. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes - Location of the 37- and 40-kDa fragments determined. J. Immunol 1997; 159: 3662–3667
   PubMedGoogle Scholar
• Aanstoot H. J., Rang S. M., Kim J., Lindsay L. A., Roll U., Knip M., et al. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD(65) and IA2 marks the early phases of autoimmune response in type 1 diabetes. J. Clin. Invest 1996; 97: 2772–2783
   PubMed Web of Science ®Google Scholar
• Aguilar-Diosdado M., Parkinson D., Corbett J., Kwon G., Marshall C. A., Gingerich R. L., et al. Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes 1994; 43: 418–425
   PubMedGoogle Scholar
• Bergman B., Haskins K. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 1994; 43: 197–203
   PubMed Web of Science ®Google Scholar
• Petersen J. S., Karlsen A. E., Markholst H., Worsaae A., Dyrberg T., Michelsen B. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 1994; 43: 1478–1484
   PubMedGoogle Scholar
• Tisch R., Liblau R. S., Yang X. D., Liblau P., McDevitt H. O. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 1998; 47: 894–899
   PubMed Web of Science ®Google Scholar
• Daniel D., Wegmann D. R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B (9–23). PNAS USA 1996; 93: 956–960
   PubMed Web of Science ®Google Scholar
• Mordes J. P., Schirf B., Roipko D., Greiner D. L., Weiner H., Nelson P., et al. Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats. Ann. N. Y. Acad. Sei 1996; 418–421, 778
   PubMedGoogle Scholar
• Petersen J. S., Mackay P., Plesner A., Karlsen A., Gotfredsen C., Verland S., et al. Treatment with GAD65 or BSA does not protect against diabetes in BB rats. Autoimmunity 1997; 25: 129–138
   PubMed Web of Science ®Google Scholar
• Gottlieb P. A., Handler E. S., Appel M. C., Greiner D. L., Mordes J. P., Rossini A. A. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depIeted diabetes resistant BB/Wor rats. Diabeto/ogia 1991; 34: 296–300
   PubMedGoogle Scholar
• Bieg S., Moller C., Olsson T., Sernmark R. The lymphopenia (lyp) gene controls the intrathymic cytokine ratio in congenic BioBreeding rats. Diabetologia 1997; 40: 786–792
   PubMed Web of Science ®Google Scholar
• Hegewald M. J., Schoenfeld S. L., McCulloch D. K., Greenbaum C. J., Klaff L. J., Palmer J. P. Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type 1 diabetes. J. Immunol. Meth 1992; 154: 61–68
   PubMedGoogle Scholar
• McCulloch D. K., Klaff L. J., Kahn S. E., Schoenfeld S. L., Greenbaum C. J., Mauseth R. S, et al. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes 1990; 39: 549–556
   PubMed Web of Science ®Google Scholar
• Falorni A., Örtqvist E., Persson B., Sernmark R. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using l3S or 3H recombinant human ligands. J. Immunol. Meth 1995; 186: 89–99
   PubMed Web of Science ®Google Scholar
• Grubin C. E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W. A., Li L., et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344–350
   PubMed Web of Science ®Google Scholar
• Karlsen A. E., Hagopian W. A., Grubin C. E., Dube S. C, Disteche M., Adler D. A., Bärmeier H., Mathewes S., Grant F. J., Foster D., Sernmark R. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. PNAS USA 1991; 88: 8337–8341
   PubMed Web of Science ®Google Scholar
• Michelsen B. K., Petersen J. S., Boel E., Moldrup A., Dyrberg T., Madsen O. D. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent mellitus. PNAS USA 1991; 88: 8754–8758
   PubMedGoogle Scholar
• Falorni A., Ackefors M., Carlberg C., Daniels T., Persson B., Robertson J., et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 1996; 39: 1091–1098
   PubMed Web of Science ®Google Scholar
• Cetkovic-Cvrlje M., Gerling I. C., Muir A., Elliot M. A., Leiter E. H. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta cell antigens. Diabetes 1997; 46: 1975–1982
   PubMed Web of Science ®Google Scholar
• Ziegler M., Schlosser M., Hamann J., Vieregge P., Luhder F., Kloting I., et al. Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes. Exp. Clin. Endoerinol 1994; 102: 98–103
   PubMedGoogle Scholar
• Elder M. E., Maclaren N. K. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J. Immunol 1983; 130: 1723–1731
   PubMed Web of Science ®Google Scholar
• Cataldo D. M., Van Nast G. A. The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice. Vaccine 1997; 15: 1710–1715
   PubMed Web of Science ®Google Scholar
• Granoff D. M., McHugh Y E, Raff H. V., Mokatnn A. S., Van Nest G. A. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide ∼CRM 197 conjugate vaccine. Infect, Im-mun 1997; 65: 1710–1715
   PubMed Web of Science ®Google Scholar
• Higgins D. A., Carlson J. R., Van Nest G. A. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. Vaccine 1996; 14: 478–484
   PubMed Web of Science ®Google Scholar
• Kim J., Namchuck M., Bugawan T., Fu Q., Jaffe M., Shi Y., et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish Stiff-Man Syndrome from insulin-dependent diabetes mellitus. J. Exp. Med 1994; 180: 595–606
   PubMed Web of Science ®Google Scholar
• Dunnovic B. I., Hummel M., Ziegler A. G. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996; 45: 795–800
   PubMedGoogle Scholar
• Harrison L. C., Honeyman M. C., DeAizpurua H. J., Schmidli R. S., Colman P. G., Tait B. D., et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341: 1365–1369
   PubMed Web of Science ®Google Scholar
• Honeyman M. C., Stone N., DeAizpurua H. J., Rowley M. J., Harrison L. C. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. J. Autoimmunity 1997; 10: 165–173
   PubMedGoogle Scholar
• Hummel M., Durinovic-Bello I., Ziegler A. G. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J. Autoimmunity 1996; 9: 427–430
   PubMedGoogle Scholar
• Bieg S., Bailyes E. M., Yassin N., Amann J., Herberg L., McGregor A. M., et al. A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice. Diabetologia 1993; 36: 385–390
   PubMedGoogle Scholar
• Brooks-Worrell B. M., Starkebaum G. A., Greenbaum C., Palmer J. P. Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J. Immunol 1996; 157: 5668–5674
   PubMedGoogle Scholar